These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21157086)

  • 1. Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity.
    Shah PK; Morris RJ; Narendran V; Kalpana N
    Indian J Ophthalmol; 2011; 59(1):73-4. PubMed ID: 21157086
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
    Hosseini H; Khalili MR; Nowroozizadeh S
    Retina; 2009 Apr; 29(4):562. PubMed ID: 19262431
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
    Nowroozzadeh MH
    Retina; 2009 Apr; 29(4):564-5; author reply 565-8. PubMed ID: 19262428
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
    Azad R; Chandra P
    Indian J Ophthalmol; 2007; 55(4):319; author reply 320. PubMed ID: 17595491
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
    Dorta P; Kychenthal A
    Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity.
    Jang SY; Choi KS; Lee SJ
    J AAPOS; 2010 Oct; 14(5):457-9. PubMed ID: 21035077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
    Mintz-Hittner HA
    Retina; 2009 Apr; 29(4):562-4. PubMed ID: 26281628
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
    Mintz-Hittner HA; Kennedy KA; Chuang AZ;
    N Engl J Med; 2011 Feb; 364(7):603-15. PubMed ID: 21323540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity.
    Eftekhari Milani A; Hassanpoor N; Mousavi Mirkala M; Taheri A; Golizade A; Niyousha MR
    Int Ophthalmol; 2020 Feb; 40(2):477-482. PubMed ID: 31712928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
    Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
    Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.
    Shah PK; Narendran V; Tawansy KA; Raghuram A; Narendran K
    Indian J Ophthalmol; 2007; 55(1):75-6. PubMed ID: 17189897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
    Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK
    Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.
    Sangtam T; Vinekar A; Maheshwar B; Dogra MR; Eong KG
    Indian J Ophthalmol; 2007; 55(4):317; author reply 317-8. PubMed ID: 17595489
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
    Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
    J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up.
    Martínez-Castellanos MA; Schwartz S; Hernández-Rojas ML; Kon-Jara VA; García-Aguirre G; Guerrero-Naranjo JL; Chan RV; Quiroz-Mercado H
    Retina; 2013 Feb; 33(2):329-38. PubMed ID: 23099498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivascular endothelial growth factor for retinopathy of prematurity.
    Mintz-Hittner HA; Best LM
    Curr Opin Pediatr; 2009 Apr; 21(2):182-7. PubMed ID: 19300261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
    Flavahan PW; Lavy TE; Wykes W
    Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
    Kusaka S; Shima C; Wada K; Arahori H; Shimojyo H; Sato T; Fujikado T
    Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
    Spandau U
    Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.